2seventy bio, Inc.
TSVT
$4.28
-$0.35-7.56%
Headlines
4/24/2024
-
Zacks Investment Research
4/24/2024
-
Zolmax
4/17/2024
-
Zacks Investment Research
4/14/2024
-
Ticker Report
4/12/2024
-
Zacks Investment Research
4/12/2024
-
Ticker Report
4/10/2024
-
Zacks Investment Research
4/8/2024
-
Zacks Investment Research
4/8/2024
-
Zacks Investment Research
4/7/2024
-
The Fly
Buy Rating and High Risk for 2seventy bio: FDA Approval and Market Expansion Fuel Optimistic Outlook
4/7/2024
-
TipRanks Financial Blog
4/5/2024
-
TipRanks Financial Blog
4/5/2024
-
The Fly
4/5/2024
-
Business Wire
4/3/2024
-
Seeking Alpha - Long Ideas
4/3/2024
-
SeekingAlpha
4/1/2024
-
Business Wire
3/28/2024
-
Zolmax
3/28/2024
-
Zolmax
3/26/2024
-
Tickeron - Technical Analysis
3/26/2024
-
Ticker Report
3/25/2024
-
Market News Video
3/24/2024
-
Zolmax
3/23/2024
-
Tickeron - Stocks
3/22/2024
-
Tickeron - Stocks
Filings
Thursday, March 7, 2024
Sunday, December 31, 2023
Week of May 6 and 10 (est)
Price History
--
--
Corporate Info
617 675 7270
60 Binney Street
Cambridge, MA 02142
Cambridge, MA 02142
Business Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company’s products pipeline...
more